Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Carcinoma, Hepatocellular 2Brain Neoplasms 2Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Leiomyoma 1Fibroadenoma 1Colorectal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1

Interventions

telapristone acetate 18ulipristal acetate 17Uterine Myomectomy 13vilaprisan 12Leuprolide 11relugolix 9estradiol, norethindrone drug combination 9asoprisnil 9elagolix 7Uterine Artery Embolization 7Mifepristone 7Estradiol 7Bupivacaine 7ulipristal 6Tranexamic Acid 6Saline Solution 5Norethindrone Acetate 5linzagolix 4epigallocatechin gallate 4Sodium Chloride 4Letrozole 4Hysterectomy 4Vitamin B 6 3Sugars 3Misoprostol 3Lidocaine 3Gonadotropin-Releasing Hormone 3Embolization, Therapeutic 3cetrorelix 2Vitamin D 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Leiomyoma × gadoterate meglumine × Clear all
NCT01514617 2024-07-10

Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization

Universitaire Ziekenhuizen KU Leuven

Phase NA Active not recruiting
100 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡